Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 262.50p 255.00p 270.00p 262.50p 262.50p 262.50p 38,224 06:40:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 20.3 4.0 8.1 32.6 112.82

Tristel (TSTL) Latest News

More Tristel News
Tristel Takeover Rumours

Tristel (TSTL) Share Charts

1 Year Tristel Chart

1 Year Tristel Chart

1 Month Tristel Chart

1 Month Tristel Chart

Intraday Tristel Chart

Intraday Tristel Chart

Tristel (TSTL) Discussions and Chat

Tristel Forums and Chat

Date Time Title Posts
14/12/201713:39The TRISTEL story2,438
15/7/201512:01Tristel PLC: Cleaning up the sector340
03/1/201004:54tristel with charts-
14/3/200612:13MRSA cleaner246
13/2/200607:10TSTL with Charts & News3

Add a New Thread

Tristel (TSTL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-12-15 16:29:20260.70191497.94O
2017-12-15 16:15:02256.85177454.62O
2017-12-15 15:49:07260.70923.46O
2017-12-15 15:40:48260.703,86910,086.48O
2017-12-15 15:20:25260.701026.07O
View all Tristel trades in real-time

Tristel (TSTL) Top Chat Posts

DateSubject
16/12/2017
08:20
Tristel Daily Update: Tristel Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 262.50p.
Tristel Plc has a 4 week average price of 250p and a 12 week average price of 238.50p.
The 1 year high share price is 322.50p while the 1 year low share price is currently 143p.
There are currently 42,979,633 shares in issue and the average daily traded volume is 69,472 shares. The market capitalisation of Tristel Plc is £112,821,536.63.
23/11/2017
15:38
zimbtrader: Thanks Melton. I had missed that detail (that it would be dilutive). I am still, nevertheless, minded to vote against the motion as a matter of principle. It still enables the directors to walk off with money for nothing (effectively) regardless of the price. HAD the motion proposed that the shares vest on any change of control provided the share price is, say, no lower than 10% of the average share price on the day the motion is passed (assuming it is), then I would be more comfortable that they will act in the best interests of ALL shareholders rather than just themselves. It smacks a little too much of greed for my liking...
22/11/2017
10:58
melton john: "they do not provide the incentive to improve the share price" One-third will vest upon the achievement of a share price of GBP3.50; One-third will vest upon the achievement of a share price of GBP4.25; One-third will vest upon the achievement of a share price of GBP5.00. Why on earth would you be happy if they vested "at or near the current share price" Have I missed something?
22/11/2017
10:25
cameronm: I hope all shareholders will vote against the proposed 1p options as they do not provide the incentive to improve the share price that is the point of granting options. I would be content if they were exerciseable at or near the current share price.
13/11/2017
21:23
james188: I very much doubt that the fall in the share price today was down to the article by Richard Beddard referenced above. In essence, it was a well written article which simply questioned whether too much future profit growth was being assumed in the share price as at the end of last week. It is less than 3 weeks ago that I bought a slug of these shares at 268p - and that was by a large distance the most I have ever paid for this share. I expect that the price will continue to bounce around. As I am still adding, I fervently hope so.
07/11/2017
23:06
briangeeee: murray80, I understand and agree that any sale would require shareholder approval. However, after the last debacle, the board should be going the extra mile. If they're confident that there won't be a sale at a lower valuation than the performance targets, then let's make the performance conditions apply equally in both situations. Why not? You comment about it being normal for options to vest on takeover. Well perhaps, but the point is that normal options are not NIL COST. That makes all the difference. With "normal" options, directors are rewarded for an uplift in share price. With NIL COST, they may well be rewarded for a reduction in share price. Surely it's very simply to change the scheme, and more importantly, the right thing to do.
02/11/2017
10:24
piedro: New Share Option Scheme The 2018 Scheme The 2018 Scheme will be put forward for approval by shareholders at the Company's Annual General Meeting. If the 2018 Scheme is approved 990,000 share options will be granted on 1 January 2018 as follows: · Paul Swinney 500,000 options; · Elizabeth Dixon 400,000 options; · Paul Barnes 45,000 options; · David Orr 45,000 options. The options will be exercisable at 1 penny per share and will vest in three equal tranches as follows: · One-third will vest upon the achievement of a share price of £3.50; · One-third will vest upon the achievement of a share price of £4.25; · One-third will vest upon the achievement of a share price of £5.00. To vest, the average share price of Tristel plc must be above the hurdle rate for a minimum three-month period In the event of a change of control of the Company all options will vest. Any vested but unexercised options will expire on 30 June 2021. As an additional condition, the options will only be exercisable if the holder commits to hold the resulting ordinary shares until 30 June 2021 or, if sooner, until a change of control of the Company occurs. - I would prefer @ £4.50, £6.00 and £7.50 - and do not enjoy the talk of change of control - a change of CEO and Chairman, yes AIMHO
22/8/2017
10:18
zimbtrader: I suppose someone also has to say it... the rising share price is, quite simply, speculation on the basis that approval will be secured unconditionally. Whilst I think it is unlikely, there remains some risk of an unexpected set-back which would only result in a negative impact on the share price. I guess we each must assess where we stand and I will freely admit I have reduced my holding recently and banked a very decent capital gain to boot. I have to admit, whilst I have learnt to be happy at having banked gains, I do still look at the continual rises with a twinge of regret that I reduced my overall holding by 40%. I am only human, after all! ;-)
20/7/2017
08:10
zimbtrader: Thank you James and Melton; both very useful for those of us that were not able to attend. The share price has reacted positively to the update and, I guess, the event. I find myself considering some further top-slicing (I topped up -a lot - below 200p). I've seen this share bubble up nicely off the back of good news only to come off the boil after a month or so which would then be an opportunity to buy back.... A profit is, after all, only a profit when it has been banked!
31/12/2016
12:47
source: Reminder from recent IC article:- "...But we continue to like Tristel, particularly given its strong intellectual property, market leading position and opportunity to expand into the US - the world’s biggest healthcare market. Buy" Seems like drops in share price are overreaction IMO. Especially as its European and Australian Markets are far more tangible opportunities in the short term and even before considering USA potential...IMHO. Regards, Source.
29/2/2016
21:05
source: Another update from Paul Scott (turning more positive)... Regards, Source. +++++++++++++ Tristel (LON:TSTL) Share price: 108.75p (up 4.6% today) No. shares: 42.2m Market cap: £45.9m (at the time of writing, I hold a long position in this share) Director purchases - I'm really not a fan of orchestrated Director share purchases after bad news, but as mentioned recently for another company, it does seem to work in some situations anyway, in helping to reassure investors. Perhaps it works in marginal situations, where confidence is beginning to return anyway, which is how I see Tristel? I reported here on 24 Feb 2016 on Tristel's interim results, and the various factors which triggered a sharp correction in the share price. My view, when the shares were at 125p at the time of writing that report, was that the price looked "a bit too high", but that the "longer term upside still looks good". The share price subsequently dropped considerably more, and went as low as the low-mid 90p's yesterday morning. At around that level, I think it was a reasonably good purchase, so I picked up a few, more of a dabble than a conviction buy. Management webinar - I was also really impressed with the webinar that TSTL management did with Equity Development yesterday lunchtime. I watched/listened, and felt that management were open in addressing the criticisms of the slowing sales growth, and the share options charge. There's no doubt they have dropped a big clanger with a badly designed share options scheme, but I think they recognise that, and were emphatic that there would be no repetition in the next 3-5 years. Various other factors mitigate my concerns over the slowing growth rate (now 8%), such as 4% being due to currency effects, and also that low margin products have been dropped - hitting turnover, but having little to no impact on profit. Overall, I take my hat off to TSTL management for being so open with private investors, and not only holding a webinar, but also a meeting in London, open to private investors. Feedback from this has also been positive. This is outstanding stuff - if only all companies were so willing to engage with their PI shareholder base - especially when contentious issues arise. TSTL is already being rewarded with a rebound in the share price. I think the glass is slowly turning from half empty, to half full again. The upside from potential US FDA approvals is something that I'd like to stick around for, as that could be a significant catalyst for future growth. I'm not sure there is necessarily much short term upside from here, but who knows? I would have thought it might recover to say 120-130p after a while.
Tristel share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171216 15:04:59